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A B S T R A C T
This paper outlines a simple label-free sensor system for the sensitive, real time measurement of an important
protein biomarker of sepsis, using a novel microelectrode integrated onto a needle shaped substrate. Sepsis is a
life threatening condition with a high mortality rate, which is characterised by dysregulation of the immune
response following infection, leading to organ failure and cardiovascular collapse if untreated. Currently, sepsis
testing is typically carried out by taking blood samples which are sent to a central laboratory for processing.
Analysis times can be between 12 and 72 h making it notoriously diﬃcult to diagnose and treat patients in a
timely manner. The pathobiology of sepsis is becoming increasingly well understood and clinically relevant
biomarkers are emerging, which could be used in conjunction with a biosensor to support real time diagnosis of
sepsis. In this context, microelectrodes have the analytical advantages of reduced iR drop, enhanced signal to
noise ratio, simpliﬁed quantiﬁcation and the ability to measure in hydrodynamic situations, such as the
bloodstream. In this study, arrays of eight (r=25 µm) microelectrodes were fabricated onto needle shaped
silicon substrates and electrochemically characterised in order to conﬁrm successful sensor production and to
verify whether the observed behaviour agreed with established theory. After this, the electrodes were functio-
nalised with an antibody for interleukin-6 (IL-6) which is a protein involved in the immune response to infection
and whose levels in the blood increase during progression of sepsis. The results show that IL-6 is detectable at
physiologically relevant levels (pg/mL) with incubation times as short as 2.5 min. Electrochemical impedance
spectroscopy (EIS) and diﬀerential pulse voltammetry (DPV) measurements were taken and DPV was concluded
to be the more suitable form of measurement. In contrast to the accepted view for macro electrodes that the
impedance increases upon antigen bind, we report herein a decrease in the micro electrode impedance upon
binding. The small size of the fabricated devices and their needle shape make them ideal for either point of care
testing or insertion into blood vessels for continuous sepsis monitoring.
1. Introduction
Sepsis is a major cause of morbidity and mortality. For example, in
the United Kingdom sepsis results in the death of 37,000 individuals per
year from a total of 150,000 cases and is responsible for more deaths
than lung, breast and colon cancer combined (NHS England, 2015). The
condition is deﬁned as “life-threatening organ dysfunction caused by a
dysregulated host response to infection”. To put this deﬁnition into
perspective, even a moderate degree of organ dysfunction is associated
with an in hospital mortality rate more than 10% and should a patient
require admission, a mortality rate in intensive care of 30%. Full details
on the consensus deﬁnition of sepsis including clinical criteria have
been described recently (Singer et al., 2016). From this it is clear that
improved diagnostic testing and patient management are required to
enhance survival rates and patient outcomes. In current practice, there
is a reliance on clinical judgment and standard laboratory techniques to
diagnose sepsis, with time lags of 12–72 h for sample analysis. For ex-
ample, a delay in sepsis diagnosis of one hour results in a 6–10% in-
crease in the chance of death (Marik, 2014). It is therefore clear that the
development of sensor technologies which evaluate levels of sepsis
biomarkers with fast analysis times has the potential to revolutionise
sepsis diagnosis and management.
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A number of biomarkers have been reported in the literature as
being useful for the diagnosis and monitoring of sepsis, in fact the total
reported is greater than 100 (Biron et al., 2015). To develop a device
capable of giving insight into the condition and its progression, it is
necessary to employ a multi marker assay. In this study, we report
development of a novel electrode system bearing 8× 50 µm-diameter
gold disc electrodes, which could be used as the platform for a multi
marker assay, and demonstrate successful detection of a common sepsis
marker.
Interleukin-6 (IL-6) is a 21 kDa glycoprotein secreted by leukocytes,
which means it is deﬁned as a cytokine: a substance which is known to
be released by cells of the immune system. It is also secreted by a
number of other cells, including: ﬁbroblasts, osteoblasts, keratinocytes,
endothelial cells, mesangial cells and tumour cells (Kobeissi and
Zanotti-Cavazzoni, 2010). It is present at elevated levels during fever
and plays an important role in the diﬀerentiation of B cells, which are
antibody-producing white blood cells. IL-6 is referred to as a pro- and
an anti-inﬂammatory cytokine because it has functions which act in
both pathways. IL-6 is also an important substance for many diﬀerent
physiological functions, for instance bone homeostasis, due to the in-
duction of osteoclast formation, and control of the body's metabolism.
In terms of sepsis, IL-6 is a widely report as being of high importance for
diagnosis and monitoring (Kibe et al., 2011; Kobeissi and Zanotti-
Cavazzoni, 2010). Clinically relevant levels of IL-6 have recently been
reported as being in the range of 5–25 pg/mL for physiologically
normal situations and up to 1000 pg/mL in the cases of patients with
sepsis (Miguel-Bayarri et al., 2012; Molano Franco et al., 2015). IL-6
and its concentration in the blood has been shown to correlate very
closely with sepsis prognosis, with levels greater than 500 pg/mL
leading to death in 11% of cases and greater than 7500 pg/mL leading
to death in 37% of cases (Miguel-Bayarri et al., 2012; Molano Franco
et al., 2015).
Microelectrode sensors have the well documented advantages of
reduced iR drop, steady state diﬀusion proﬁles, insensitivity to con-
vection and simpliﬁed quantiﬁcation (Sosna et al., 2007). There are
examples of successful fabrication of microelectrode sensors for che-
mical (Blair et al., 2015; Corrigan et al., 2014) and biological sensing
(Corrigan et al., 2018; Quan Li et al., 2017). Herein, electrochemical
impedance spectroscopy (EIS) and diﬀerential pulse voltammetery
(DPV) are tested as detection strategies because both allow the non-
destructive, label-free study of interfacial phenomena at electriﬁed in-
terfaces (Fig. 1). In EIS, by applying a small sinusoidal excitation po-
tential and measuring the corresponding current response it is possible
to probe several physical phenomena, which include: the solution
resistance (RS), the double layer capacitance (CDL), the charge transfer
resistance (RCT) and the diﬀusion impedance (Warburg impedance – W)
(Lisdat and Schäfer, 2008). Due to the fact that EIS is highly sensitive to
changes at the electrode surface it is possible to monitor the binding of
biological molecules in real time and in a label free manner (Quan Li
et al., 2017). There are literature reports of eﬀective immunosensors
prepared using macroelectrodes (Ciani et al., 2012; Eissa and Zourob,
2012; Moschou et al., 2016). A common approach for the EIS based
detection of protein biomarkers is to immobilise a sensing ﬁlm com-
posed of antibodies for the target analyte onto the electrode and mea-
sure alterations to RCT when the target is bound. Previously developed
point of care assays for IL-6 require the use of additional reagents such
as sandwich assays, complex electrode preparation steps, e.g. mod-
iﬁcation with nanomaterials to improve electron transfer kinetics and
optical detection techniques (Kemmler et al., 2014, 2009) or complex
electrode modiﬁcations (Yang et al., 2013). In this study, we demon-
strate clinically relevant levels of sensitivity without the requirement
for such electrode modiﬁcations or labelling steps. Alongside EIS, DPV
measurements were tested since these produce a well-deﬁned peak
current, are label-free, rapid (< 20 s), exclude non-Faradaic current
contributions (due to the excitation potential waveform employed) and
do not require complex interpretation such as equivalent circuit ﬁtting
(as is the case for EIS). Furthermore, the instrumentation required for
DPV measurements is simple to implement at low cost. Finally, whilst
many immunosensors have been successfully developed for a range of
protein biomarkers using traditional electrodes, very few studies have
successfully utilised true microelectrodes (r≤ 50 µm) for im-
munosensor development. The novelty of this work lies in the demon-
stration of a micofabricated multi-electrode array which has potential
to measure important biomarkers in near real time. The system reported
here simpliﬁes electrode preparation (no need for grafting of electron
transfer improving materials, e.g. graphene or nanoparticles) and has a
fast time to result at clinically relevant IL-6 concentrations. Further-
more, it oﬀers the possibility for label-free in situ monitoring for sepsis
by integrating the sensor with a cannula within the bloodstream.
2. Materials and methods
2.1. Chemicals and reagents
IL-6 antibodies and antigen were purchased from Abcam
(Cambridge, UK), Enterotoxin A, sulfuric acid, dithiothreitol (DTT),
sulfosuccinimidyl 6-[3'-(2-pyridyldithio) propionamido] hexanoate
(sulfo-LC-SPDP), potassium ferricyanide, ferrocyanide, human serum
Fig. 1. (A) Electrochemical sensor principle for the antibody functionalised microelectrode including EIS and DPV measurements. (B) the modiﬁed Randles’
equivalent circuit for a microelectrode. (C) EIS and DPV responses observed with the microelectrodes used in this study.
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(sterilised) and phosphate buﬀered saline tablets were all purchased
from Sigma Aldrich (Poole, Dorset, UK). The chemicals and reagents
used for the needle electrode microfabrication are detailed in the next
section.
2.2. Needle electrode microfabrication
A silicon wafer with a 1-µm-thick thermal oxide was patterned using
lift-oﬀ lithography (Shipley S1830 photoresist with chlorobenzene
treatment) to deﬁne a hard etch mask (100-nm-thick thermal evapo-
rated chromium). Using reactive ion etching (15 sccm Ar / 15 sccm
CHF3; 100W; chamber pressure 0.026 mBar), the exposed SiO2 was
etched, and the chrome mask later removed with a selective wet etch
(Chromium Etchant 1020; Fig. 2.C.ii). Lift-oﬀ lithography was again
used to pattern the single electrical layer comprising of interconnects
and electrical contacts (8× 50-µm-diameter disks, 1× 300 *80 µm
reference); the metal used was Ti: Au, 10:150 nm thick (Fig. 2.C.iii). A
second patterned hard mask (200 nm thick thermal evaporated copper)
was used for an isotropic reactive ion etch of silicon (5 sccm O2 / 25
sccm SF6; 100W; chamber pressure 0.16 mBar) to deﬁne 40-µm-deep
mesas (Fig. 2.C.iv). The isotropy of the etching allows the blade-like
side wall of the needle to reduce dimpling and insertion force required
to penetrate tissue (Hosseini et al., 2007). The copper etch mask was
removed with a selective wet etch (iron nitrate solution) and a 5-µm-
thick SU8 2005 (MicroChem) passivation layer was patterned pro-
tecting the electrical interconnects, and deﬁning the area of the exposed
contact (Fig. 2.C.v). The devices were protected using unexposed pho-
toresist (S1813) and wax (Logitech quartz wax), before the reverse side
of the silicon wafer was mechanically thinned using alumina grit (9 µm
grit size) on a Logitech PM5 lapping and polishing machine, then po-
lished using SF1 polishing ﬂuid. Dissolving the wax in trichloroethylene
mechanically released the silicon needles, which were later cleaned of
the protective layer of photoresist in acetone (Fig. 2.C.vi). The ﬁnished
40-µm-thick needle electrodes were designed with a 240-µm-wide, 2.1-
mm-long silicon tang with a taper and opening angle was 30° to further
reduce the insertion force.
The electrodes were optically inspected then mounted onto a
printed circuit board. Electrical interconnects were made between the
gold bonding disks (LEW Technologies) on the copper tracks to the gold
contacts on the needles using gold wire ball bonding (Fig. 2A–B). These
wires were later passivated using varnish.
2.3. Sensor preparation and electrochemical measurements
Gold micro disc electrodes (r=12.5 µm) were employed in order to
perform benchmark cyclic voltammetry (CV), diﬀerential pulse vol-
tammetry (DPV) and electrochemical impedance spectroscopy (EIS)
measurements. Previous studies give detailed accounts of
microelectrode characterisation experiments and protocols (Corrigan
et al., 2018; Quan Li et al., 2017). An Autolab PGSTAT208 (Metrohm-
Autolab B.V., Utrecht, Netherlands) under PC control was employed for
electrochemical measurements. The reference electrode employed was
a silver/silver chloride electrode in 3.0M potassium chloride. The
counter electrode was a platinum foil.
The electrode surface was functionalised by reacting equal volumes
of the antibody stock solution (1mg/mL anti Il-6 antibody, Abcam,
Cambridge, UK) with 40mM Sulfo-LC-SPDP (Sigma, Aldrich, UK) in 1 x
PBS for 40mins. The mixture was then incubated with an equal volume
of 150mM DTT (Sigma Aldrich, UK) for 1 h on a mixing plate to pro-
vide agitation. 10 µL of the solution was then drop coated onto the chip
ensuring all electrodes were covered. The electrodes were stored in a
humidity chamber for 16 h to allow antibody immobilisation and SAM
formation to take place with the high humidity prevented evaporation
of the drop. Following this, electrodes were rinsed with 1 x PBS and
incubated for 1 h in 1mM 6-mercapto-1-hexanol to backﬁll any un-
occupied sites on the electrode surface. The electrode arrays were then
left to equilibrate in 1 x PBS for 1 h prior to beginning detection of the
IL-6 antigen. Further detail on the electrode functionalisation protocol
can be found in a previous publication ().
EIS measurements were carried out at open circuit potential in 1 x
PBS buﬀer containing 10mM potassium ferricyanide and 10mM po-
tassium ferrocyanide. For the AC excitation signal, a total of 50 fre-
quencies were employed ranging from 100,000–0.1 Hz (spaced loga-
rithmically) using an amplitude of 10mV rms. Data were ﬁtted using
the Randles’ equivalent circuit and modiﬁed Randles’ equivalent circuit
(Fig. 1B). For some EIS responses it was necessary to ﬁt with a modiﬁed
version of the circuit (e.g. use of a resistor in parallel with the Warburg
element in order to model hemispherical diﬀusion to a microelectrode).
DPV measurements were performed using the default settings of the
potentiostat instrument which were a scan rate of 0.01 Vs-1, a mod-
ulation amplitude of 0.025 V, a step potential of 5 mV and a modulation
time of 0.05 s.
2.4. Baseline measurements with commercial screen printed electrodes
Baseline measurements were performed using 1.6 mm Au diameter
screen printed electrodes (DropSens - Au233 BT – Oviedo Spain).
Electrodes were pre-treated by using an established protocol which
involved holding the potential at 2 V for 120 s followed by 10 cycles
between -0.25 and 1.5 V with a sweep rate of 0.1 Vs-1. Once prepared
the immobilisation protocol described above was employed to func-
tionalise the surface. Impedance measurements were then carried out
before and after incubation with IL-6 solutions.
Fig. 2. (A) Image of a packaged device for electrochemical testing. (B) Image of the needle shaped electrode bearing 8× 50 µm gold disc electrodes. (C) Outline of
fabrication process employed for device production.
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3. Results and discussion
3.1. Initial microelectrode characterisation
Electrodes were cleaned by cycling the voltage between -1.0 and
0.75 V for 10 cycles at a sweep rate of 100 mVs-1 with the maximum
current limited to 100 nA in 0.1 M KCl and then transferred into a
measurement buﬀer containing the redox agent potassium ferri-ferro-
cyanide and 1×PBS as the supporting electrolyte. Cyclic voltammetry
was performed using a range of scan rates along with DPV and EIS
measurements to fully characterise the fabricated electrode system. It
can be seen from Fig. 3 (A&B) that a sigmoidal CV response was re-
corded which is indicative of a microelectrode response and the de-
velopment of steady state diﬀusion proﬁles during electrolysis. In ad-
dition, the CV responses showed a scan rate independence with the
limiting current (IL) values remaining broadly similar across the range
of scan rates tested. There was a very slight capacitive contribution as
sweep rate increased which is evident in Fig. 3B. This has been ob-
served before with microfabricated microelectrode sensors and is at-
tributed to parasitic capacitances (Corrigan et al., 2014). To aid with
quantitation of the response the experimentally measured limiting
current was compared to that calculated using the Saito equation which
describes the limiting current at a microdisc electrode (Eq. (1)):
=I nFDcr4l (1)
where IL is the limiting current, n the number of electrons transferred, F
is Faraday's constant, D is the diﬀusion coeﬃcient and r the electrode
radius. The experimentally determined value for IL upon the reduction
of potassium ferricyanide to ferrocyanide was found to be −6.65 nA.
When the theoretical limiting current was calculated using a literature
value of 7.17× 10-6 cm2s-1 for D (Konopka and McDuﬃe, 1970), a
value of 6.9 nA was obtained. This is in good agreement with the ex-
perimentally observed current and the slight discrepancy can be ex-
plained by the recessed nature of the disc electrode (which results from
the photolithographic production method) leading to a slight reduction
in current compared to a ﬂush disc where the diﬀusion regime is un-
hindered.
To further evaluate the performance of the microelectrode sensor,
the EIS response was ﬁtted using the Modiﬁed Randles’ equivalent
circuit for a microelectrode (see Fig. 1B) (Woodvine et al., 2010). The
ﬁtted values for RCT and RNL were 7.46 kΩ ± 1.19% and 10.087MΩ
± 1.02% and the overall χ2 ‘goodness of ﬁt’ was 0.004 indicating a
highly satisfactory ﬁt to the equivalent circuit. The ﬁt can be visualised
in Fig. 3D as the red line. The equations which allow estimation of these
circuit parameters are outlined below
=R
RT
nFi
4
NL
L (2)
=
∞
R
RTL
ADF c
4
CT 2 (3)
where in addition to the previous Eq. (1) L is the diﬀusion length and A
is electrode area. Using these equations it was possible to calculate
Fig. 3. Electrochemical characterisation of an r=25 µm disc electrode. (A) Cyclic voltammetry (CV) at 10 mVs-1. (B) Cyclic voltammetry over a range of sweep rates
(10, 25, 50 and 100 mVs-1). (C) Diﬀerential pulse voltammetry (DPV). (D) Electrochemical impedance spectroscopy (EIS) recorded at open circuit potential.
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theoretical values of 6.79 kΩ for RCT and 9.01MΩ for RNL. It is im-
portant to point out that these values correspond well to the values
obtained from equivalent circuit ﬁtting and discrepancies can be ac-
counted for by the uncertainty associated with estimating L, the slight
contribution of double layer charging to the estimation of IL and the
slightly recessed nature of the electrode. These electrochemical results
present a compelling case for the successful fabrication of the micro-
electrode array, with similar analyses previously reported in the lit-
erature to conﬁrm successful microelectrode production using micro-
fabrication (Corrigan et al., 2018; Terry et al., 2013).
3.2. Macro and microelectrode measurements of IL-6 binding
First of all, measurements of IL-6 binding were recorded using
commercially sourced gold screen printed electrodes (SPEs) to serve as
a comparison for the sensors located on the microneedle devices. These
benchmark measurements were performed after ﬁrst producing a SAM
layer on the electrode surfaces which contained cross linked IL-6 anti-
bodies and employed 6-mercapto-1-hexanol as a backﬁlling agent to
prevent non-speciﬁc adsorption of analytes. This approach has been
shown to produce eﬀective immunosensing assays on gold SPE devices
with detection limits for diﬀerent antibody-antigen complexes in the
pg/mL to fg/mL range. The measurements reported in this section were
performed by testing samples of IL-6 antigen which had been prepared
by spiking the protein into 1×PBS buﬀer at known concentrations and
then incubating at room temperature on the anti-IL-6 antibody func-
tionalised SPE.
The results for the SPEs indicate that the overall EIS response is
typical of a macroelectrode with a semi-circle for RCT followed by the
beginning of a 45° straight line which is representative of linear
Warburg diﬀusion (Fig. 4A). Through equivalent circuit ﬁtting to the
established Randles’ circuit (Fig. 1B), it is clear that RCT increased
slightly from the initial value following a ten-minute incubation of the
electrode with 25 pg/mL IL-6 antigen in 1×PBS (see SI Table S1).
After establishing a baseline eﬀect with the SPEs, equivalent measure-
ments were performed with the microelectrode array.
The EIS response from the microelectrode sensor was evaluated pre
and post incubation for 25 pg/mL IL-6 antigen and in this case it was
found that the overall impedance for the electrode decreased following
incubation with target antigen (see Fig. 4B). Both RCT and RNL were
found to drop, indicating an increase in eﬀective electrode area upon
IL-6 binding (see SI Table S2). Interestingly, RCT showed the greater
percentage decrease in signal (74%) vs RNL (14%) which ﬁts with the
expected response and previous data (Quan Li et al., 2017). This de-
monstrates that the surface area dominated RCT reaction was a more
sensitive measurement of receptor occupancy than RNL which is a proxy
for limiting current and is governed by electrodes radius rather than
area (see Eqs. (2) and (3)). The ﬁnding of an increase in redox current
upon IL-6 binding was also corroborated by DPV measurements which
showed the peak current increased following successive incubations
with IL-6 antigen. This is a surprising result since it is normally an-
ticipated that RCT increases upon exposure to target molecules in a
biological binding reaction, as observed above with the commercial
gold SPEs. To eliminate the possibility of experimental factors com-
pounding the results, the tests were repeated several times alongside
gold SPEs thus ruling out any defect in the antibody immobilisation or
condition. In contrast to these results, it has been repeatedly reported
that for macroelectrode based assays using the Faradaic impedance
principle, RCT increased upon successful capture of the target analyte
(Corrigan et al., 2013; Ianeselli et al., 2014). Studies involving small
electrodes (r < 50 µm) are much less common and the use of im-
pedance as a detection technique on such small electrodes is even less
frequently reported.
To determine if the unexpected drop in the impedance was unique
to the needle electrodes and IL-6 combination, we undertook a series of
experiments on diﬀerent electrode systems. Firstly, we immobilised IL-6
onto glass pulled microelectrodes (r=12.5 µm) and carried out antigen
incubations following the same protocol used for the needle array. The
same eﬀect was observed and RCT decreased upon incubation with
target antigen. We next explored whether a decrease in RCT could be
observed when measurements were performed using the needle mi-
croelectrode array with DNA as the bio-receptor molecule instead of IL-
6 (SI, Fig. S1). A DNA sensing ﬁlm was immobilised on the electrode
surface using an established protocol (Quan Li et al., 2017) and again
RCT was found to decrease following target binding. This suggests a
common mechanism for SAM ﬁlms formed on small electrode surfaces,
whereby a decrease in RCT and an increase in DPV peak current were
indicative of target-analyte binding.
Irrespective of the direction of the impedance change, it was clear
from comparing the macroelectrode response (Fig. 4A) that the sensi-
tivity of the microelectrode to IL-6 was enhanced, with larger changes
in the electrochemical signal apparent after 2.5min incubation time,
which is 75% faster than observed with the gold SPEs. Next, DPV
measurements were carried out and analysed in order to provide ef-
fective comparison with the EIS based approach.
3.3. DPV measurements of IL-6 binding
Fig. 3C shows the initial DPV response of an unmodiﬁed micro-
electrode and Fig. 5A shows the change in DPV current from baseline
with increasing IL-6 antigen concentration. These results indicate there
was a decrease in DPV peak current from approximately 5.4 nA (clean
electrode presented in Fig. 3C) to approximately 0.46 nA following
immobilisation of the antibody layer. This is indicative of a well formed
Fig. 4. Electrochemical characterisa-
tion of IL-6 antibody modiﬁed elec-
trodes. (A) EIS response of a gold SPE
macro electrode pre and post incuba-
tion (10mins) with 25 pg/mL IL-6. (B)
EIS responses from an r=25 µm disc
electrode pre and post incubation
(2.5mins) with 25 pg/mL IL-6. Arrows
indicate direction of RCT change upon
IL-6 binding.
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SAM which initially hampers redox agent access to the electrode surface
until antigen binding increases redox agent accessibility. Furthermore,
it can be seen that peak current increased with increasing IL-6 con-
centration following 2.5min incubation periods. This result is con-
sistent with the behaviour observed in the EIS measurement, i.e. RCT
decreased following target-antigen binding and this provides further
evidence that the reported eﬀect is an appropriate basis for sensor
operation. A number of immunosensors operating on the DPV principle
have been reported in the literature, showing a decrease in peak current
with increasing antigen concentration (Eissa et al., 2013;
Molazemhosseini et al., 2016) and is widely accepted as the normal
case for macroelectrode sensors. To corroborate the ﬁndings of this
study, i.e. the reverse eﬀect, there is an example from the literature of
an electrochemical sensor which also produced an increase in DPV
current upon antibody-antigen binding and again involved electrodes
with well-deﬁned micro and nano features (Yi et al., 2014). The authors
attribute the increase in peak current to increased surface accessibility
for the redox couple following bio-recognition. Following on from the
ﬁnding reported in Fig. 5A, a dose response eﬀect was established for
IL-6 modiﬁed microelectrodes (see Fig. 5B) which shows increasing
DPV peak current with increasing IL-6 concentration. Between 0 and
60 pg/mL the sensor showed linear behaviour. At 80 and 100 pg/mL
concentrations the current response increases in a non-linear fashion,
perhaps to give a sigmoidal curve upon saturation of all binding sites.
This result gives conﬁdence in the sensor response and also shows the
device is sensitive to IL-6 concentration changes in the most clinically
applicable concentration range (20–100 pg/mL) which is indicative of
the onset of an inﬂammatory response caused by sepsis. These data
therefore demonstrated the suitability of DPV for measurement of an-
tibody-antigen binding, i.e. a convenient, fast, sensitive measurement of
immunocomplex formation without the requirement for labelling or
complex electrode modiﬁcations.
3.4. Validation of IL-6 binding measurements and demonstration of assay
sensitivity and speciﬁcity in samples simulating a biological medium
To simulate a situation more closely related to direct measurements
in blood through e.g. sensor implantation, or measurement from a
blood sample, the IL-6 antigen was spiked into solutions of 5% BSA
(bovine serum albumin) and the sensor performance evaluated. This
experiment provided the opportunity to assess the needle microelec-
trode array performance in the presence of potentially interfering
protein species in the antigen containing incubation solution, a strategy
employed in other studies (Kumar et al., 1999; Liu et al., 2013; Tomás
et al., 2017). Additionally, these experiments were repeated in tripli-
cate in order to characterise the variation inherent in both the elec-
trodes, SAM formation and the measurement protocol. Given the con-
sistency of behaviour between the EIS and DPV measurements, only
DPV was used to assess performance in 5% BSA. First, using three
electrodes from an array, sensors were incubated with IL-6 (100 pg/mL)
for time intervals of 0, 2, 5, 15 and 60mins. This concentration was
selected because it represents a deviation from the normal baseline (IL-
6 ~ 25 pg/mL) which is indicative of sepsis and is therefore diag-
nostically useful. Fig. 6A shows the resulting plot from this experiment
and it can be seen that across the sixty minute time course there was a
signiﬁcant increase in peak current which was indicative of antigen-
antibody binding. Like most immunosensors the device shows a sa-
turation of signal which is indicative of full occupancy of all available
binding sites on the sensor surface.
Demonstrating the speciﬁcity of the sensor is also a key factor in
determining its performance and so to provide an example of speciﬁc vs
non-speciﬁc interactions two incubation solutions were prepared. First,
250 pg/mL Enterotoxin A and second 25 pg/mL IL-6, both in 5% BSA
solution. After baseline measurements, the Enterotoxin A solution was
incubated on the electrode for 2.5 min and the peak current recorded,
followed by a ﬁnal incubation in 25 pg/mL IL-6 solution for 2.5min.
Again, this concentration was chosen because it is close to the physio-
logically normal concentration for IL-6 and is therefore a suitable de-
monstration of the ability to measure quickly at or around the clinically
relevant threshold. The higher concentration of Enterotoxin A (250 pg/
mL) was used to demonstrate non-speciﬁc binding with the non-speciﬁc
protein ten-fold higher in concentration than the ligand. These results
can be seen in Fig. 6B and provide a clear demonstration of the increase
in DPV peak current resulting from the speciﬁc antibody-antigen in-
teraction for IL-6 versus the negligible change in peak current for in-
cubation with Enterotoxin A solution. This is the expected behaviour for
an immunosensor, i.e. its operating principle is the speciﬁc interaction
between antibody and antigen but this result serves as an eﬀective
demonstration of sensor speciﬁcity.
To explore the performance of the sensor in a more clinically re-
levant sample, short incubations were made by exposing electrodes to
IL-6 spiked into human serum at a concentration of 100 pg/mL, human
serum without IL-6 spiked in and phosphate buﬀer without IL-6 for
2.5 min (Fig. 6C). DPV measurements show a clear increase in peak
current due to IL-6 binding in human serum. In contrast the serum-only
incubation and the phosphate buﬀer control show only slight increases
in peak current. This slight increase on the electrode exposed only to
serum is most probably explained by non-speciﬁc protein binding
slightly aﬀecting the current. Overall, these ﬁndings give conﬁdence
that the microfabricated electrode substrates can serve as the basis of an
immuno assay for IL-6 and other protein biomarkers of inﬂammation
and sepsis.
Fig. 5. (A) Example DPV peak currents following 2.5 min incubations with
diﬀerent concentrations of IL-6. (B) DPV peak current dose response curve re-
corded across a range of ﬁve IL-6 concentrations (0, 20, 40, 60, 80 and 100 pg/
mL). n= 3 and bars represent S.D.
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Having fabricated, characterised and functionalised the sensor it is
important to give due consideration to the observed phenomenon of a
consistent decrease in RCT and concomitant increase in DPV peak
current upon IL-6 antigen target binding. This is most likely attributable
to the formation of a densely packed SAM layer on the microelectrode
sensor surface with high internal stresses and through which channels
are exposed upon antigen binding allowing the redox couple better
access to the electrode surface and therefore decreasing RCT. There are
examples in the literature of SAM forming protocols used to char-
acterise microelectrode SAMs and which report the need for additional
equivalent circuit elements to account for diﬀerences in the micro-
electrode response compared to the macro, for example an extra resistor
can be included to model the development of well-deﬁned pinholes
which arise through use of agents such as 6-mercapto-1-hexanol
(Sheﬀer et al., 2007) as monolayers. Here, it could be that binding of
the IL-6 antigen is exposing additional pin holes in the 6-mercapto-1-
hexanol layer which results in increased redox current because ferri-
ferrocyanide is given better access to the electrode surface.
Similar explanations have been previously discussed in the litera-
ture for analogous eﬀects observed on biologically modiﬁed small
electrodes. Interestingly, when the χ2 ‘goodness of ﬁts’ were analysed (SI
Table S1), it can be seen that the χ2 value for the global ﬁt improved
following target binding. Since the ﬁt was made to the established
equivalent circuit for microelectrodes, it could be inferred that IL-6
antibody-antigen binding and presentation of channels through the
SAM ﬁlm produced a response more typical of a microelectrode com-
pared to the antibody functionalised electrode prior to target exposure.
As previously mentioned, the eﬀect was observed consistently when we
repeated the test using glass pulled microelectrodes and also when we
functionalised microfabricated microelectrode devices with single
stranded probe DNA and bound a fully complementary target (SI Fig.
S1).
There are also reports in the literature of RCT reductions upon target
binding with ferri-ferrocyanide as redox mediator when electrodes are
modiﬁed with nanoscale features and are employed for detection
(Manzanares-Palenzuela et al., 2016). These eﬀects are attributed to the
geometry of small electrodes opening up pores upon target hybridisa-
tion (Prasad et al., 2013), diﬀerences in the density of the sensing layer
formed on micro/nanoelectrodes (Yi et al., 2014; Zhang et al., 2014)
and screening of surface charges upon target binding (Jolly et al.,
2015). We anticipate IL-6 carrying a net negative surface charge at the
pH used to run the assay (assay pH = 7.4, isoelectric point of IL-6 ~
6.7) (Rees et al., 1999) so believe net charge to be unlikely to account
for the dose dependant decrease in RCT, especially when a redox species
with net negative charge such as ferri-ferro-cyanide is used as the re-
porter molecule. Critically, in situations where an RCT decrease has
been observed, experiments have been performed to show the decrease
is not due to removal of the SAM layer. What is clear from this study is
that the sensor displayed a consistent and dose dependant response to
IL-6, in spiked buﬀer, in both 5% BSA and human serum, in addition the
observed behaviour included typical immunosensor eﬀects (saturation
of signal upon full occupation of binding sites and high IL-6 selectivity
as demonstrated by reduced sensitivity to a non-speciﬁc protein, in this
case Enterotoxin A). The reported eﬀects relating to the nature of the
change in RCT on the microelectrode devices are interesting and merit
further investigations.
In this study, the absolute sensitivity of the device is not fully elu-
cidated since detection focused upon the clinically relevant threshold of
20 pg/mL. Since Faradaic and non-Faradaic impedance measurements
have been shown to be approximately equally sensitive this sensor can
be potentially operated in both formats (Fernandes et al., 2014). When
contrasting with the literature there are recent sensitivity reports for a
number of biological analytes including DNA (Jin et al., 2017), dopa-
mine (Jin et al., 2018b) and protein biomarkers (Gui et al., 2018; Jin
et al., 2018a) with stated sensitivities of 0.01–1 pM (DNA), 1 nM (do-
pamine) and 0.3 – 500 pM (protein). With a sensitivity level of 20 pg/
mL (0.95 pM) established here and using short incubation times; the
sensor is competitive with current literature examples and is certainly
clinically relevant.
Fig. 6. (A) DPV peak current versus incubation time for microelectrodes ex-
posed to IL-6 antigen (n=3). (B) DPV peak current for microelectrodes in-
cubated in buﬀer, with 250 pg/mL Enterotoxin A and 25 pg/mL IL-6 (n= 3)
error bars in both plots represent S.D. (C) DPV peak current for microelectrodes
incubated in buﬀer, with human serum and 100 pg/mL IL-6 spiked into human
serum for 2.5 min (n=3) error bars in all plots represent S.D.
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4. Conclusions
In this work, microfabrication has allowed production of needle
shaped arrays of microelectrodes. When characterised, the expected
microelectrode response was observed from the sensors on the chip.
Next, chemical functionalisation and assay development in buﬀer al-
lowed EIS and DPV measurements of IL-6 antibody modiﬁed electrodes.
This work showed that using the electrode functionalisation protocol in
combination with small electrode sensors resulted in the trend of a
decrease in impedance (RCT) and an increase in DPV peak current fol-
lowing incubation with antigen samples at clinically relevant con-
centrations (e.g. 20 pg/mL). This eﬀect can serve as the basis of an
analytical measurement and was further tested against a non-speciﬁc
protein analyte, in solutions containing BSA as a mimic of a complex
sample and with IL-6 samples spiked into human serum. This sensor is
an attractive candidate for further development, since beyond a SAM, it
does not require any complex electrode modiﬁcations such as e.g. gold
nanoparticles, graphene oxide sheets etc. and that the sensing principle
was in eﬀect label-free (the assay does not require a labelling step).
Crucially the changes in the electrochemical signals were greater for the
microelectrode devices than the SPEs tested and allowed detection of
IL-6 concentration changes label-free and in near real time. Future work
will involve development of other biomarker measurements on the chip
to produce a comprehensive panel for sepsis diagnosis and improve-
ment of the SAM layer through changes to surface functionalisation
chemistry.
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